I am adding some LXRX here today. I still really feel this one is a solid buy out play. They remind me of CPXX. I felt they were a buyout play and it played out that way. LXRX had solid results on their type 1 diabetes and they are going to be testing the same drug on type 2. They have a drug for Carcinoid Syndrome that looks like approval is around the corner. They just bought back all their Remaining Obligations To Symphony Icon as well. Then on top of that their cash hoard looks very attractive.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.